Barriers and Facilitators to the Implementation of Personalised Medicine across Europe
(1) Background: Personalised medicine (PM) is an innovative way to produce better patient outcomes by using an individualised or stratified approach to disease and treatment rather than a collective approach to treating patients. PM is a major challenge for all European healthcare systems. This arti...
Main Authors: | Dorota Stefanicka-Wojtas, Donata Kurpas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/13/2/203 |
Similar Items
-
Personalised Medicine—Implementation to the Healthcare System in Europe (Focus Group Discussions)
by: Dorota Stefanicka-Wojtas, et al.
Published: (2023-02-01) -
eHealth and mHealth in Chronic Diseases—Identification of Barriers, Existing Solutions, and Promoters Based on a Survey of EU Stakeholders Involved in Regions4PerMed (H2020)
by: Dorota Stefanicka-Wojtas, et al.
Published: (2022-03-01) -
BARRIERS AND FACILITATORS FOR HEALTHCARE PROFESSIONALS TO IMPLEMENTING A PREHABILITATION PROGRAMME: REVIEW OF THE LITERATURE
by: Olivia Chapman, et al.
Published: (2021-09-01) -
How personalised medicine will transform healthcare by 2030: the ICPerMed vision
by: Astrid M. Vicente, et al.
Published: (2020-04-01) -
Integrating China in the international consortium for personalised medicine. a position paper on healthcare professionals’ education and citizens’ empowerment in personalised medicine
by: Flavia Beccia, et al.
Published: (2023-06-01)